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Abstrak
Latar belakang: Reaksi transfusi akut (RTA) merupakan sekelompok kejadian yang tidak diinginkan akibat 
pemberian transfusi darah. Manifestasi dari RTA bervariasi dari yang ringan hingga mengancam nyawa. Saat 
ini, data mengenai reaksi transfusi di Indonesia masih sangat terbatas. Dalam studi ini, kami bertujuan untuk 
memberikan gambaran mengenai karakteristik RTA dan faktor-faktor yang mempengaruhinya.
Metode: Studi ini merupakan studi retrospektif yang melibatkan 288 subyek dengan RTA. Studi dilakukan di 
Rumah Sakit Dr. Cipto Mangunkusumo, dimulai sejak Januari hingga Desember 2017. RTA dikelompokkan 
berdasarkan sistem tubuh yang mengalami manifestasi, serta derajat manifestasinya.
Hasil: Sel darah merah merupakan produk darah utama yang ditransfusikan ke subyek, diikuti dengan konsentrat 
trombosit, plasma segar beku, dan kriopresipitat. Lima gejala utama dari RTA adalah gatal, demam/kenaikan suhu 
tubuh, menggigil, urtikaria, dan angioedema. Berdasarkan sistem tubuh yang terkena, umumnya RTA bermanifestasi 
sebagai gejala pada kulit (56.6%). Berdasarkan derajat manifestasinya, RTA umumnya dikategorikan dalam derajat 
ringan (55.9%). Anak-anak cenderung mengalami manifestasi yang ringan (64.8%) dan utamanya bermanifestasi 
pada kulit (65.4%). Riwayat transfusi mempengaruhi derajat RTA secara signifikan. RTA derajat sedang dan gejala 
konstitusional lebih banyak ditemukan pada subyek yang mendapat PRC dibanding produk darah lainnya.
Kesimpulan: Umumnya RTA bermanifestasi sebagai gejala dermatologi. Hanya sedikit kasus RTA yang 
disebabkan oleh reaksi inkompatibilitas. Manifestasi dan derajat RTA juga dipengaruhi oleh umur, riwayat 
transfusi, dan jenis komponen darah. (Health Science Journal of Indonesia 2019;10(1):15-20)
Kata kunci: Transfusi darah, reaksi transfusi akut, riwayat transfuse, usia 
Abstract 
Background:  Acute transfusion reactions (ATRs) are a group of adverse events caused by blood 
transfusions. Manifestations of ATRs vary from mild to life threatening. At present, data about 
transfusion reactions in Indonesia are still limited. In this study, we aim to determine the characteristics 
of ATRs and its related factors.
Methods: This was a retrospective study of 288 subjects with ATRs. The study was conducted in Cipto 
Mangunkusumo Hospital, started from January to December 2017. ATRs were categorized based on the 
body systems affected and degree of manifestations.
Results: Packed red cells (PRC) was the predominant blood product (51.4%) which was transfused to subjects, 
followed by thrombocyte concentrate (TC), fresh frozen plasma (FFP), and cryoprecipitate. Five most common 
predominant symptoms of ATRs were pruritus/itch, febrile/increased temperature, chills, transient urticaria, and 
angioedema. Based on the affected body systems, the majority of ATRs manifested as dermatologic symptoms 
(56.6%). Based on the degree of manifestations, the majority of ATRs were categorized as mild degree (55.9%). 
Children tended to have milder symptoms (64.8%), which mostly manifested as dermatologic symptoms 
(65.4%). History of transfusion affected the degree of ATR significantly. Moderate degree of ATRs and 
constitutional symptoms were found more common in subjects who received PRC than other blood products.
Conclusion: Most of ATRs manifest as dermatologic symptoms, which represent allergic reactions. Only 
a small portion of ATRs are caused by incompatibility reactions. The manifestation and degree of ATRs 
are also affected by age, history of transfusion, and type of blood components.  (Health Science Journal 
of Indonesia 2019;10(1):15-20)
Keyword: Blood transfusion, acute transfusion reaction, transfusion history, age 
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Acute transfusion reactions (ATRs) are a group of 
adverse events which occur within 24 hours after 
starting blood transfusion. Transfusion reactions 
are the most common side effects related to blood 
products administration. Previous studies reported 
various incidence rate of transfusion reactions, 
started from 0.4% to 1.1%.1,2 In the mild form, the 
most common manifestation was feeling discomfort, 
which was found in 0.16% patients.2 Around 0.14% 
of transfusion reactions manifested as breathing 
problems, which is life-threatening and need 
immediate treatments.2,3 
Transfusion reactions are divided into two main groups: 
non-hemolytic transfusion reactions and hemolytic 
transfusion reactions. Acute non-hemolytic transfusion 
reactions vary from mild pruritus, transient urticaria, 
febrile non-hemolytic transfusion reaction (FNHTR) 
to most fatal form like transfusion-related acute lung 
injury (TRALI). Acute hemolytic transfusion reactions 
are usually the result of incompatibility of red blood 
cell donor with patient’s antibody. The symptoms are 
various, including sudden onset of febrile or chills, 
hypotension, dyspnea, hemoglobinuria, disseminated 
intravascular coagulation, and acute renal failure.4
Hemovigilance is a set of systematic procedures 
to detect any adverse events and incidences in the 
whole transfusion chain, from the collection of 
blood, processing blood products, until follow up of 
its recipients. Hemovigilance is very important to 
prevent any adverse events related to blood product 
transfusion.5 
Understanding the characteristics of transfusion 
reaction and its contributing factors are important 
to construct plan in facing transfusion reactions. 
At present, there are limited data about transfusion 
reactions in Indonesia. Therefore, in this study, 
we aim to determine the characteristics of acute 
transfusion reactions and its relations with other 
contributing factors. 
METHODS
This was a retrospective descriptive study conducted 
at Cipto Mangunkusumo Hospital, an Indonesian 
national referral hospital. The data of transfusion 
reactions were obtained from inpatients and 
outpatients from all unit/department in the hospital. 
This study started from January to December 2017. 
Total sampling was preferred to produce more 
reliable results. 
In our center, transfusion reactions were categorized 
into three different degree: 1) mild (e.g. localized 
erythema, pruritus, mild rash, transient urticaria/
flushing); 2) moderate (e.g. unexplained febrile ≥ 
39oC, temperature rise ≥ 2oC, chills, rigors, multiple 
rash, nausea, vomiting, myalgia, angioedema/
wheezing/persistent urticaria without signs of 
circulatory problems); 3) severe (e.g. hypotension, 
any signs of shock, dyspnea, severe stridor, 
angioedema, anaphylaxis, chest pain, headache, 
bleeding, and hemoglobinuria). 
Meanwhile, based on the affected body systems, 
transfusion reactions were grouped into dermatologic 
(e.g. edema, erythema, pruritus, flushing), respiratory 
(e.g. dyspnea, wheezing), constitutional (e.g. chills, 
febrile, rigors, diaphoresis, pain), neurological (e.g. 
seizure, dizziness, lethargy, agitation, twitching), and 
circulatory symptoms (hypotension, tachycardia). 
The experiment used archive materials which do not 
have link with patient information.
RESULTS
Transfusion reactions were occurred in 288 subjects 
(0.5%) from a total of 57.227 patients received 
blood transfusion. Table 1 showed that the number 
of children subjects (56.6%) were greater than adults 
(43.4%). No significant difference was observed 
between the number of male and female subjects. 
Packed red cells/PRC (51.4%) was the predominant 
blood product which caused transfusion reactions, 
followed by thrombocyte concentrate/TC (43.4%), 
fresh frozen plasma/FFP (4.2%), and cryoprecipitate 
(1.0%). A total of 51.4% of subjects had past 
transfusion history.
There were many manifestations of acute transfusion 
reactions (Table 1). Five most common predominant 
symptoms of ATRs were pruritus/itch (27.4%), 
febrile/increased temperature (19.1%), chills 
(14.2%), transient urticaria (9.7%), and angioedema 
(7.7%). 
ATRs could be classified by several indicators. 
Based on the affected body system, the majority 
of subjects had dermatologic (56.6%) and 
constitutional symptoms (34.4%). Based on the 
degree of transfusion reaction, most of subjects had 
mild (55.9%) and moderate (33.0%) manifestations 
(Table 2).
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Table 1. Characteristic of subjects
Characteristics n (%)
Age
≤ 18 years 163 (56.6)














Febrile or temperature rise 55 (19.1)
Chills 41 (14.2)








Table 2. Classification of transfusion reactions.
Transfusion reaction categories n (%)
Systems involved
Dermatologic symptoms 163 (56.6)
Constitutional symptoms 99 (34.4)
Respiratory symptoms 18 (6.3)
Circulatory symptoms 6 (2.1)
Neurological symptoms 2 (0.7)




Due to some limitations, we proceeded further 
evaluation in only 64 subjects or 50.4% of total 
subjects with moderate and severe manifestations. 
Table 3 showed that no incompatibility was found in 
70.3% of the evaluations. Major incompatibility was 
found in two subjects with manifestation of febrile 
and chills. Minor incompatibility with positive 
donor HLA antibody was detected in one subject, 
which presented with TRALI. Antibodies in the rest 
of minor incompatibility results were undefined.
Table 3. Detection of incompatibility
Type of incompatibility n (%) Manifestation
Major incompatibility
anti-E 1 (1.6) Febrile and chills
anti-E and anti-c 1 (1.6) Febrile and chills
Minor incompatibility
anti-HLA antibody 1 (1.6) TRALI
Undefined antibody 16 (25) variative
No incompatibilty 45 (70.2)
Most of children subjects had dermatologic symptoms 
(65.4%), while manifestations in adult subjects 
were dominated by dermatologic and constitutional 
symptoms (42.2%). Age of the subject affected the 
manifestation significantly (p=0.001). History of past 
transfusion did not affect the manifestation significantly 
(p=0.109). Mostly, subjects who got TC, FFP, and 
cryoprecipitate showed dermatologic symptoms 
(72.8%, 83.3%, and 100%, respectively). Interestingly, 
constitutional symptoms were the most common 
manifestations in patients who got PRC (Table 4). 
Age of the subject also affected the degree of transfusion 
reactions significantly (p=0.001). Most of children subjects 
showed mild manifestations, while adult subjects showed 
mild and moderate manifestations. Past transfusion history 
also affected the degree of manifestations (p=0.022). Severe 
manifestations were found more common in patients 
without transfusion history (15.7%) than patients with 
transfusion history (6.7%). The majority of patients who 
got TC, FFP, and cryoprecipitate had mild manifestations. 
Meanwhile, patients who got PRC transfusion commonly 
had moderate (43.2%) and mild (42.6%) manifestations 
(Table 5).
DISCUSSIONS
In our study, we found PRC was the blood component 
that contributes the most acute transfusion reactions, 
followed by TC, FFP, and cryoprecipitate. The main 
explanation for this is the fact that the most common 
blood components being transfused in order are PRC, 
TC, FFP, and cryoprecipitate. Other studies also found 
similar results. Study in Japan revealed that the incidence 
of transfusion reaction per transfusion unit was higher in 
TC (3.8%), compared to FFP (1.3%), and PRC (0.6%).6 
Meanwhile, another study in India revealed that the 
highest incidence of transfusion reactions was occurred 
in patients receiving PRC (1.4%) and FFP (0.6%), but 
transfusion reactions never occurred in patients receiving 
TC.7 These discrepancies may be explained by the fact 
that the transfusion reactions are affected by several 
factors, including ethnicity and clinical diagnosis.8,9
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In total, allergic reactions (pruritus/itch, transient 
urticaria, rash, etc) and febrile were the most common 
manifestations of ATR. This result was consistent 
with Bassi R study, which found that the most 
common clinical features of transfusion reactions 
were FNHTR and allergic reaction.10 Allergic 
reactions are caused by reaction of recipient’s IgE 
with allergen from donor, leading to release of 
mediators from mast cells. Several allergens that has 
been documented are donor’s plasma protein (IgA 
and haptoglobin), chemical allergens (methylene 
blue in FFP preparation), and food allergen. Allergic 
reactions are also caused by passive transfer of 
antibodies and passive sensitization, when IgA and 
IgE-specific antibodies are infused from donor to 
patient.11 Other studies found that allergic transfusion 
reactions might occur without allergen involvement, 
especially in platelet transfusions. Stored platelet 
concentrates contain accumulated inflammatory 
cytokines and chemokines, which directly bind 
to receptors in mast cells and basophils, called 
biological response modifiers (BRMs), including 
vascular endothelial growth factor, sCD40 ligand, 
and transforming growth factor-β1.12,13
Anaphylactic reactions (hypotension, bronchospasm, 
angioedema, etc) are the severe form of allergic 
reactions. It is caused by interaction of recipient’s 
antibody with donor’s plasma protein including IgA, 
haptoglobin, complement, and ethylene dioxide [11]. In 
case of anaphylaxis, IgG mediated mechanisms plays an 
important role, beside Ig-E mediated mechanisms. IgG 
specific allergen binds to FcγRs and causes subsequent 
release of platelet-activating factor (PAF) from basophil. 
In this mechanism, PAF is the major mediator for 
systemic anaphylaxis, rather than histamine.12
Febrile, rise in temperature, and chills are caused by 
interaction of WBC antigen – antibody and consequent 
cytokines release. Some cytokines that has been 
identified as the primary cause of febrile related 
transfusion are interleukin (IL)-1β, IL-6, IL-8, and tumor 
necrosis factor α, which are released from leukocytes by 
acute hemolytic process (febrile hemolytic transfusion 
reaction/FHTR) or during storage (FNHTR).11,14-16 
In our study, we found two cases of major 
incompatibility of rhesus antigen. One subject had 
anti-E, while the other had anti-E and anti-c, both in 
pre-transfusion and post-transfusion blood samples. 
Table 4. Factors affecting predominant symptoms of transfusion reactions
Symptoms, n(%) p value
Dermatologic Constitutional Respiratory Circulation Neurological
Age
0.001
≤ 18 years 117 (65.4) 53 (29.6) 6 (3.4) 2 (1.1) 1 (0.6)
> 18 years 46 (42.2) 46 (42.2) 12 (11.0) 4 (3.7) 1 (0.9)
Past transfusion history
0.109
Yes 94 (63.5) 45 (30.4) 8 (5.4) 0 (0) 1 (0.7)
No 69 (49.3) 54 (38.6) 10 (7.1) 6 (4.3) 1 (0.7)
Type of blood products
N/A
PRC 59 (39.9) 70 (47.3) 12 (8.1) 5 (3.4) 2 (1.4)
TC 91 (72.8) 27 (21.6) 6 (4.8) 1 (0.8) 0 (0)
FFP 10 (83.3) 2 (16.7) 0 (0) 0 (0) 0 (0)
Cryoprecipitate 3 (100) 0 (0) 0 (0) 0 (0) 0 (0)






≤ 18 years 116 (64.8) 52 (29.1) 11 (6.1)
> 18 years 45 (41.3) 43 (39.4) 21 (19.3)
Past transfusion history
0.022
Yes 92 (62.2) 46 (31.1) 10 (6.7)
No 69 (49.3) 49 (35.0) 22 (15.7)
Type of blood products
N/A
PRC 63 (42.6) 64 (43.2) 21 (14.2)
TC 85 (68.0) 29 (23.2) 11 (8.8)
FFP 10 (83.3) 2 (16.7) 0 (0)
Cryoprecipitate 3 (100) 0 (0) 0 (0)
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Interestingly, manifestations that appeared in both 
subject were only fever and chills. Other symptoms 
of acute hemolytic transfusion reactions (e.g. flank 
pain and hemoglobinuria), which usually appear in 
major incompatibility transfusion reaction cases, did 
not appear.17 The symptoms resolved after transfusion 
was stopped and administration of acetaminophen and 
antihistamine IV. Goodell PP study demonstrated that 
85.7% of patients with positive non-ABO incompatibility 
did not show any symptoms of transfusion reactions 
[18]. Besides, rhesus antigen C, c, E, and e are less 
immunogenic than antigen D.16 The patient had under-
went crossmatch analysis before transfusion, but the 
result was negative. Therefore, antibody screening before 
transfusion was conducted in our center since mid 2017.
One subject showed signs and symptoms of TRALI 
during administration of PRC. Further examination 
proved that the subject had minor incompatibility, and 
HLA antibody was detected in blood donor. Antibodies 
of a quarter of subjects with incompatibility could 
not be determined. They had various manifestations, 
including febrile, chills, urticaria, and angioedema. 
National Blood Bank plays an important role to 
assure that the donor with HLA antibody is excluded 
for further donation of any blood products.11 In this 
study, we found that children tended to have milder 
ATRs than adults. Dermatologic symptoms, which 
represent allergic reaction, were found more common 
in children. The same results were also found by 
Oakley FD study, which demonstrated the incidence 
of allergic transfusion reaction between children and 
adults were 2.7/1000 and 1.1/1000.19 
In this present study, we observed that from the total 
subjects who experienced transfusion reactions, the 
number of subjects with past transfusion history was 
almost equal to the number of subjects who never got 
transfusions. Moreover, subjects with transfusion history 
tended to have milder symptoms and mostly manifested 
as allergic reactions. This result can be explained by Kato 
H study which showed that first transfusion incidences 
of allergic reactions are higher than on subsequent 
transfusions.20 On the contrary, Gwaram BA study 
showed previous transfusion history increased the 
risk of getting transfusion reactions.21 Pedrosa AKKV 
study found that previous history of transfusion was 
not significantly associated with the type of transfusion 
reactions.22 These discrepancies may be explained 
because the study population characteristics (including 
race) and type of blood being used in the practice are 
different from one study to others.
Most of subjects with PRC transfusion had constitutional 
symptoms, while subjects who received other blood 
products transfusion had dermatologic symptoms. 
Similar result was also found in Cho J study, which 
observed that the most common cause of FNHTR was 
RBC transfusion.23 This can be explained by the fact that 
PRC has the greatest number of leukocytes, followed by 
TC, FFP, and cryoprecipitate.24 Previous study proved 
that the prevalence of FNHTRs was reduced in the 
pre-storage leukocyte-reduced RBC transfusion and 
the prevalence of allergic reactions was reduced in the 
pre-storage leukocyte-reduced platelets transfusion.15 
It is hardly to determine whether allergic reactions 
following platelet transfusion are caused by plasma 
proteins or BRMs, but there is general agreement that 
the decreased amounts of plasma protein will reduce 
the risk of allergic reactions.12
Limitation of this study is not all subjects with moderate 
or severe transfusion reactions can be proceeded into 
further examinations. Other limitations are lack of data 
about leuco-filtration status for each blood component 
and the occurrence time of each transfusion reaction. 
Therefore, further studies with adding these variables 
are needed to fully comprehend the characteristics of 
transfusion reaction and its related factors, especially 
in Indonesian population.
In conclusion, PRC is the most common blood product 
received by subjects with transfusion reaction. ATRs 
predominantly manifest as dermatologic symptoms, 
which represent allergic reactions. Only a small portion 
of the ATRs are caused by incompatibility reactions. 
ATRs of PRC usually manifest as constitutional 
symptoms. ATRs of other blood components mostly 
manifest as allergic reactions. Children usually have 
milder ATRs, which are frequently presented as 
dermatologic symptoms. History of transfusion also 
affects the degree of ATRs. 
From this study, we suggest for every blood 
transfusion practitioner to obtain full transfusion and 
adverse reactions history prior to transfusion. It is 
mandatory to closely monitor any adverse reactions 
related to transfusion, from the mildest to the most 
severe one. For patients receiving PRC, medical 
team members must be ready if any constitutional 
symptoms appeared, while for patients receiving 
other blood components, medical team members 
must be ready encounter allergic reactions. 
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